HIGHLIGHTS
- who: Giannis Mountzios et al. from the NewYork-Presbyterian, United StatesAthens, Greece, Portsmouth Hospitals University, National Health System (NHS) Trust have published the paper: Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways, in the Journal: (JOURNAL) of 18/07/2022
SUMMARY
Thoracic malignancies, lung cancer, chemotherapy, immunotherapy, resistance, molecular pathways COPYRIGHT Editorial on the Research Topic Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways Chemotherapy and immunotherapy, administered sequentially or concurrently, represent the current standard of care for most patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.